Description
RT20 + TRZ40 — 60MG Research Blend
RT20 + TRZ40 is a dual-compound research formulation containing 20MG of Retatrutide and 40MG of Tirzepatide, providing a combined total of 60MG per vial.
This product is supplied for qualified laboratory and analytical research involving peptide composition, characterization, assay development, receptor-related research models, and other controlled in-vitro applications.
Contents:
Retatrutide — 20MG
Tirzepatide — 40MG
Total Research Material — 60MG
This product is strictly intended for Research Use Only (RUO) and is not manufactured, labeled, or sold for diagnostic, therapeutic, cosmetic, veterinary, or clinical applications.
For Research Use Only. Not for human or animal use. Not for consumption.


